Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Operations And Comprehensive Loss (Unaudited)

v3.22.1
Consolidated Statements Of Operations And Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Net revenue $ 10,166 $ 8,116
Cost of revenue 5,437 5,375
Gross profit 4,729 2,741
Operating expenses:    
Sales and marketing 4,814 3,553
General and administrative 2,577 3,358
Engineering and development 1,544 1,803
Loss on patent litigation settlement 89
Total operating expenses 8,935 8,803
Loss from operations (4,206) (6,062)
Loss on foreign currency transactions (120) (204)
Interest expense, net (433) (575)
Non-operating gain (loss), net (553) (779)
Loss before income tax (provision) benefit (4,759) (6,841)
Income tax (provision) benefit (17) (60)
Net income (loss) (4,776) (6,901)
Other comprehensive loss items:    
Foreign currency translation adjustments (41) (148)
Comprehensive income (loss) (4,817) (7,049)
Net income (loss) (4,776) (6,901)
Deemed dividend on convertible preferred stock (217) (532)
Net loss attributable to common stockholders $ (4,993) $ (7,433)
Net loss per share attributable to common stockholders:    
Basic and Diluted - Note 1 $ (0.81) $ (1.38)
Shares used in the calculation of net loss per share:    
Basic and Diluted - Note 1 6,159 5,383